Drug safety update: Gabapentin (Neurontin): risk of severe respiratory depression
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update for Gabapentin...
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news
More News: Brain | Depression | Drugs & Pharmacology | Gabapentin | Neurology | Neurontin | Respiratory Medicine